KBS Corporate Advises on the Sale of marketing company
Bartlett Davis Communications Limited was established in 2003 and began trading as Bartlett Davis Communications. The company provides a wide range of marketing services for the pharmaceutical sector, specialising in media buying and placement both on and offline.
Bartlett Davis Communications has nurtured an excellent reputation and a prestigious blue-chip client base including Pfizer, AstraZeneca, BMS, Boehringer Ingelheim and Astellas, Bausch and Lomb. This client list has contributed to the company currently representing 20% of all money spent on pharmaceutical brand advertising, securing Bartlett Davis Communications as the UK market leader. The company benefits from a global reach due to ‘Approved Supplier’ status to nine of the world’s top 20 pharmaceutical companies.
The shareholders engaged KBS Corporate’s services in order to ease their retirement plans.
Following the implementation of a highly successful research strategy, 31 interested parties came forward which produced three buyer meetings and two competing offers. The success offer came from OneHealth Communications Group, previously trading as Home Marketing Limited. The buyer was obtained through KBS Corporate Crossmatch system. This marks OneHealth Communications Group second acquisition with KBS Corporate in the past 18 months.
Bartlett Davis Communications commented on the deal,
“We are delighted to announce that as of 29th August 2019, Bartlett Davis Communications have become part of the ONEHealth Communications family. This will give us access to the DATA4NHS email base – 400,000 verified NHS emails to give our clients highly targeted access to lucrative healthcare professionals. This is an exciting innovation that will only enhance our media buying service and evolve our media buying offering across the healthcare industry.”
Corporate Deal Executive, Matthew Sibley, advised our client throughout the process.